SODIUM ZIRCONIUM CYCLOSILICATE (Lokelma®)

Clinical Indication

Chronic hyperkalaemia in CKD

Comments

In line with NICE TA599.

Use in line with the CKD pathway

Date of classification

November 2019

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .